about
Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomasIncidence trend of malignant polyps through the data of a specialized colorectal cancer registry: clinical features and effect of screening.Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.Aberrant crypt foci in patients with colorectal cancer.Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk.MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events.Th inducing POZ-Kruppel Factor (ThPOK) is a key regulator of the immune response since the early steps of colorectal carcinogenesis.A founder MLH1 mutation in families from the districts of Modena and Reggio-Emilia in northern Italy with hereditary non-polyposis colorectal cancer associated with protein elongation and instability.Aetiology of colorectal cancer and relevance of monogenic inheritance.MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria.Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer.Histology of aberrant crypt foci in the human colon.Clinical outcome of low- and high-risk malignant colorectal polyps: results of a population-based study and meta-analysis of the available literature.Clinical and molecular characterization of colorectal cancer in young Moroccan patients.MSH3 protein expression and nodal status in MLH1-deficient colorectal cancers.Epidemiology of colorectal cancer: the 21-year experience of a specialised registry.Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility.Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: a population-based study.A case of pneumatosis cystoides intestinalis mimicking familial adenomatous polyposis.Incidence, clinical features and possible etiology of early onset (≤40 years) colorectal neoplasms.Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study.Analysis of mismatch repair gene mutations in Turkish HNPCC patients.Clinical and molecular features of attenuated adenomatous polyposis in northern Italy.Microsatellite instability and colorectal cancer prognosis.Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas.Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors.Duodenal carcinoma in a 37-year-old man with Cowden/Bannayan syndrome.Tumour spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with "suspected HNPCC". A population-based study in northern Italy. Colorectal Cancer Study Group.An unusual case of familial adenomatous polyposis with very early symptom occurrence.Relative role of APC and MUTYH mutations in the pathogenesis of familial adenomatous polyposis.BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigrees.Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis.Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes.Investigation of APC mutations in a Turkish familial adenomatous polyposis family by heterodublex analysis.Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCCGenotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancerAnalysis of telomere dynamics in peripheral blood cells from patients with Lynch syndromeLanthanide doped upconverting colloidal CaF2 nanoparticles prepared by a single-step hydrothermal method: toward efficient materials with near infrared-to-near infrared upconversion emissionPrognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinomaAttenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations
P50
Q28250809-F612D240-AF23-47C2-A7F8-4A21E59409F1Q30670490-C27BC81C-8D5D-4D2C-BDFA-89AFE8EE426FQ30852730-4837D07C-5CFB-4B79-AC32-EE3B2D557106Q32058667-1DB207AB-CFFA-4AC3-B593-23BCAD91B762Q33366187-F3496D62-6616-429E-B4AB-B5B0F0A5E566Q33765170-C9F2BC7E-0778-4630-821B-6B9AE3F4BA9EQ34563178-828DB34E-0BE6-4241-81EF-7BEAD2879C2AQ35445142-07BA2709-CF30-4753-85D8-515CF0E4763EQ35596248-05BC5A2E-75FC-4020-ACE9-7BA4667B224BQ36213262-113F4DBC-6D43-4686-9989-379B5F7BDBE1Q36696628-7ADCAF85-62FD-4761-AF0E-737FB80DB861Q36860193-361F91CB-7BAC-4E3C-ABF6-A222C1AA70D6Q37997363-DE5281C3-904C-4B65-BE6B-FD96760B9E38Q38903811-B8666895-0DC9-414A-8493-2DC03F08E669Q39365686-24D77801-44FC-41EE-803E-42CC81ACBD44Q40146719-426D1D1C-22BC-41F6-9888-DE3EFBCA0F0BQ41061594-F50B200E-C793-46B6-A3E5-7A752001A9D2Q43508231-577A289E-2338-489F-AB2E-77DA2FCC5C16Q44096880-5559389A-A459-4B23-B7C3-4A6C8CDB8946Q44175657-DA0AF037-C680-4D3E-AEBE-613BBB9A96D0Q44546847-E9894A57-C56B-4C5D-AD55-7D5D251A4B9CQ45805261-490FDC18-07D3-49A5-9615-E132285C7BDEQ46386484-255A7BB2-8FB0-4A25-A28B-E05DBB691EB8Q46831092-977D3D5B-7A1B-401C-9A46-006EF6FB7455Q47236302-1D82AE71-7F5C-4258-B53F-A3403D596D0AQ47550364-6DA1B866-4448-44BA-86AA-870283C2D755Q53134559-D7B8BA7B-BA54-40CB-8C36-4441CFFC3D2AQ53389780-48B71B2C-2003-4BEE-96FC-8A493EE79422Q54290279-00864655-A78F-4840-9202-AA601F5E0F91Q54401831-0BE42055-76DD-44A6-83CD-C2F476DFF479Q54447420-36EEE0C2-EBEE-46CA-BC22-CA1ADFB36CDDQ54458298-C62008A7-85BC-47C1-A5F7-36460457C566Q54478476-228D3E78-E7AE-46E7-82A2-EC66479466B3Q54491190-B760F339-2C1F-4DD0-B202-B67F33721FB2Q57737903-A5F64FC4-D0CD-4C15-92E9-174072701531Q57737908-A451EED9-4E63-4482-88EE-BA5BB35A9790Q61195888-215C77D2-A040-416D-9A4B-01B5184922E5Q61195892-390816DB-CB40-4D61-B203-8E0BB2C45D1BQ61195931-A8088B8F-2CBA-4467-B70E-967CEB64B55DQ61195941-C549BE99-8E66-42E5-9924-AC81C1AAB268
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Monica Pedroni
@ast
Monica Pedroni
@en
Monica Pedroni
@es
Monica Pedroni
@nl
Monica Pedroni
@sl
type
label
Monica Pedroni
@ast
Monica Pedroni
@en
Monica Pedroni
@es
Monica Pedroni
@nl
Monica Pedroni
@sl
prefLabel
Monica Pedroni
@ast
Monica Pedroni
@en
Monica Pedroni
@es
Monica Pedroni
@nl
Monica Pedroni
@sl
P1053
C-9384-2015
P106
P1153
7004745378
P21
P31
P3829
P496
0000-0001-5374-5362